Selenium Sulfide

CHEMBL1200680 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
111.0 g/mol
LogP
Phase
4

Selenium sulfide is a topical antifungal and antiseborrheic agent used to treat seborrheic dermatitis, dandruff, tinea versicolor, and atopic dermatitis-associated scaling. It reduces Malassezia yeast colonization through direct antifungal activity while also slowing epidermal cell turnover through its cytostatic effects on keratinocytes. It is available as shampoos and lotions for topical application.

Masse moléculaire

111,0400 g/mol

TPSA

32,10 Ų

Aires thérapeutiques

Mécanisme d'action

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

S=[Se]=S

InChI

InChI=1S/S2Se/c1-3-2

Molecular Formula

SSe

HBD / HBA

- / 1

Liaisons Rotatives

0

Atomes Lourds

2

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Selenium sulfide is a topical antifungal and antiseborrheic agent used to treat seborrheic dermatitis, dandruff, tinea versicolor, and atopic dermatitis-associated scaling. It reduces Malassezia yeast colonization through direct antifungal activity while also slowing epidermal cell turnover through its cytostatic effects on keratinocytes. It is available as shampoos and lotions for topical application.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Selenium Sulfide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200680. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24011. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.